How To Stop Premature Ejaculation

Discover how to stop premature ejaculation and how to last longer in bed.

Entries Tagged ‘European Phase’

Small caps round-up: Ten Alps/BT, Monitise, Plethora… – ShareCast

Small caps round-up: Ten Alps/BT, Monitise, Plethora…
ShareCast, UK - 8 hours ago
Plethora Solutions's final analysis of its European Phase III double-blind placebo controlled study of PSD502 for the treatment of premature ejaculation met

Sciele Pharma and Plethora Solutions Announce Positive Phase III … – PR-Inside.com (Pressemitteilung)

Sciele Pharma and Plethora Solutions Announce Positive Phase III
PR-Inside.com (Pressemitteilung), Austria - Nov 9, 2008
European Phase III double-blind placebo-controlled study of PSD502 for the treatment of premature ejaculation ('PE') has met its three co-primary endpoints

Plethora's European Phase III premature ejaculation study meets … – Pharmaceutical Business Review

Plethora's European Phase III premature ejaculation study meets
Pharmaceutical Business Review - Nov 7, 2008
(p<0.0001) and a six point difference between PSD502 and placebo in the index of premature ejaculation (IPE) domain for sexual satisfaction (p<0.0001),

London pre-open: Slim loss to start – ShareCast

London pre-open: Slim loss to start
ShareCast, UK - 36 minutes ago
Urology drug specialsit Plethora Solutions says its key premature ejaculation drug has met all of its goals in a European phase III trial.

Sciele Pharma and Plethora Solutions Announce Positive Phase III … – Business Wire (press release)


Business Wire (press release)
Sciele Pharma and Plethora Solutions Announce Positive Phase III
Business Wire (press release), CA - Nov 7, 2008
There are currently no approved pharmaceutical treatments for premature ejaculation. PSD502 is applied locally "on demand" and is effective within five
Plethora: Plethora reports positive outcomes of European Phase III Proactive Investors UK
all 14 news articles

Friday's news and tips – Investors Chronicle

Friday's news and tips
Investors Chronicle, UK - Nov 7, 2008
Urology drug specialist Plethora Solutions says its key premature ejaculation drug has met all of its goals in a European phase III trial.

Plethora premature ejaculation drug meets goals – Reuters UK

Plethora premature ejaculation drug meets goals
Reuters UK, UK - Nov 6, 2008
L: Quote, Profile, Research) said on Friday its premature ejaculation drug has met all of its goals in a phase III trial. The company said PSD502,
Sciele Pharma and Plethora Solutions Announce Positive Phase III Business Wire (press release)
Plethora: Plethora reports positive outcomes of European Phase III Proactive Investors UK
Plethora hits target in European trial ShareCast
Hemscott - GrowthBusiness.co.uk
all 14 news articles